Isabelle Kwan

Isabelle Kwan

Auto-generated profile, based on publicly available information

Isabelle Kwan

Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, New York; Renaissance School of Medicine, Stony Brook University, Stony Brook, New York

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2019 in Neurosurgery
Verified
Journal Article
Closed access
KPKomal Preet
Komal Preet
VOVera Ong
Vera Ong
JSJohn P Sheppard
John P Sheppard
MUMethma Udawatta
Methma Udawatta
CDCourtney Duong
Courtney Duong
IYIsaac Yang
Isaac Yang
BACKGROUND: Vestibular schwannomas (VS) are benign tumors derived from Schwann cells ensheathing the vestibulocochlear nerve. The retrosigmoid (RS) surgical approach is useful to resect tumors of multiple sizes while affording the possibility of preserving postoperative hearing. OBJECTIVE: To conduct a systematic review of published literature investigating hearing preservation rates in patients who underwent the RS approach for VS treatment. METHODS: The PubMed, Scopus, and Embase databases were surveyed for studies that reported preoperative and postoperative hearing grades on VS patients who underwent RS treatment. Hearing preservation rates were calculated, and additional patient demographic data were extracted. Tumor size data were stratified to compare hearing preservation rates after surgery for intracanalicular, small (0-20 mm), and large (>20 mm) tumors. RESULTS: Of 383 deduplicated articles, 26 studies (6.8%) met eligibility criteria for a total of 2034 patients with serviceable preoperative hearing, for whom postoperative hearing status was evaluated. Aggregate hearing preservation was 31% and 35% under a fixed and random effects model, respectively. A mixed effects model was used to determine hearing preservation rates depending on tumor size, which were determined to be 57%, 37%, and 12% for intracanalicular, small, and large tumors, respectively. Significant cross-study heterogeneity was found (I2 = 93%, τ2 = .964, P < .01; Q = 287.80, P = < .001), with rates of hearing preservation ranging from 0% to 100%. CONCLUSION: Tumor size may have an effect on hearing preservation rates, but multiple factors should be considered. Discussion of a patient's expectations for hearing preservation is critical when deciding on VS treatment plans.

1 September 2019 in World Neurosurgery
Verified
Journal Article
Closed access
MUMethma Udawatta
Methma Udawatta
IKIsabelle Kwan
Isabelle Kwan
KPKomal Preet
Komal Preet
TNThien Nguyen
Thien Nguyen
VOVera Ong
Vera Ong
IYIsaac Yang
Isaac Yang

27 December 2024 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Closed access
IKIsabelle Kwan
Isabelle Kwan
RKRaisa Karim
Raisa Karim
MSMarkus August Seeliger
Markus August Seeliger

5 November 2018 in Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
KPKomal Preet
Komal Preet
IKIsabelle Kwan
Isabelle Kwan
MUMethma Udawatta
Methma Udawatta
TNThien Nguyen
Thien Nguyen
VOVera Ong
Vera Ong
IYIsaac Yang
Isaac Yang
Vestibular schwannomas (VS) are benign intracranial neoplasms arising from the eighth cranial nerve. In recent years, advancing radiological techniques have provided successful non-invasive alternatives for VS therapy. RESEARCH QUESTION: How do the long-term clinical outcomes vary for the three current radiation modalities of stereotactic radiosurgery (SRS), fractionated stereotactic radiotherapy (FSRT), and hypofractionated stereotactic radiotherapy (hypoFSRT)? A retrospective chart review was conducted for all patients with unilateral VS at a single academic medical center from 2000 to 2017. Audiograms, physical examinations, and patient-reported symptoms were extracted to assess hearing, facial function and sensation, and statuses of tinnitus, vertigo, and imbalance. Sixty patients were identified (33 FSRT cases, 21 SRS cases, and 6 hypoFSRT cases). Post-operative onset of vertigo and tinnitus demonstrated significant difference between the three modalities (p = 0.035, 0.005). Survival rate analysis revealed the survival time to tinnitus onset also varied significantly when comparing SRS and FSRT (p = 0.050). SIGNIFICANCE: This study aims to elucidate the hearing and facial preservation of the three radiological interventions, thus enabling physicians to optimize patient care.